Therapeutic effect of orally administered microencapsulated oxaliplatin for colorectal cancer
Colorectal cancer is a significant source of morbidity and mortality in the United States and other Western countries. Oral delivery of therapeutics remains the most patient accepted form of medication. The development of an oral delivery formulation for local delivery of chemotherapeutics in the ga...
Main Authors: | Urbanska, Aleksandra M., Guajardo, Gonzalo, Karagiannis, Emmanouil, Anderson, Daniel Griffith, Langer, Robert S |
---|---|
Other Authors: | Harvard University--MIT Division of Health Sciences and Technology |
Format: | Article |
Language: | en_US |
Published: |
Elsevier
2015
|
Online Access: | http://hdl.handle.net/1721.1/99404 https://orcid.org/0000-0003-0131-6552 https://orcid.org/0000-0001-5629-4798 https://orcid.org/0000-0003-4255-0492 |
Similar Items
-
Rational Design of a Biomimetic Cell Penetrating Peptide Library
by: Urbanska, Aleksandra M., et al.
Published: (2014) -
An oxaliplatin(IV) prodrug-based supramolecular self-delivery nanocarrier for targeted colorectal cancer treatment
by: Lim, Wei Qi, et al.
Published: (2020) -
Beta-Hydroxybutyrate Augments Oxaliplatin-Induced Cytotoxicity by Altering Energy Metabolism in Colorectal Cancer Organoids
by: Sever, Tolga, et al.
Published: (2023) -
Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems
by: Subramanian, Deepak A., et al.
Published: (2022) -
Gut microbiota in colorectal cancer: biological role and therapeutic opportunities
by: Pandey, Himani, et al.
Published: (2023)